Sign In
Buy WEAV
$6.95
+0.0600 (+0.87%)
At Close: Jul 29, 2026
Weave to Announce Second Quarter 2026 Financial Results on August 6, 2026
04:10pm, Monday, 20'th Jul 2026
LEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, today announced it will release its financial res
Weave Launches Authorized Integration with Elation Health, Significantly Reducing Manual Workflows for Primary Care Practices
08:00am, Friday, 17'th Jul 2026
LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, today announced a new authorized inte
Weave Expands Enterprise-Ready Platform to Deliver Greater Security, AI-powered Automation, and Streamlined Front-office Workflows
11:00am, Tuesday, 14'th Jul 2026
[url="]Weave (NYSE: WEAV)[/url], a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, today announced a new se
Weave Expands Enterprise-Ready Platform to Deliver Greater Security, AI-powered Automation, and Streamlined Front-office Workflows
10:09am, Tuesday, 14'th Jul 2026
LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, today announced a new set of platform
Weave Communications: Why Its Shift To Consumption Pricing Makes It A Buy Opportunity
02:27am, Monday, 13'th Jul 2026
Weave Communications earns a Strong Buy rating with a $9.60/share target, driven by a shift to hybrid, usage-based AI pricing. Q1 revenue grew 17.4% YoY to $65.5M, with gross margin rising to 73.2% an
Weave Earns Prestigious 2026 USA TODAY Top Workplaces Award
08:00am, Thursday, 09'th Jul 2026
LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, announced that it has earned the pres
Weave Ranks No. 1 in G2's Summer 2026 Patient Relationship Management Grid Report
08:00am, Wednesday, 08'th Jul 2026
LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, has been named the No. 1 Leader in G2
KILN TO ANCHOR HOSPITALITY-DRIVEN FLEXIBLE WORKSPACE AND COMMUNITY HUB IN THE WEAVE AT OCVIBE
11:00am, Monday, 15'th Jun 2026
New Partnership Brings World-Class Coworking to OCVIBE, Reinforcing Anaheim's Evolution into a Dynamic Destination for Business, Culture, and Entertainment ANAHEIM, Calif., June 15, 2026 /PRNewswire/
Weave Bio Enables Global Submissions From a Single Source of Truth
08:00am, Monday, 15'th Jun 2026
SAN FRANCISCO--(BUSINESS WIRE)---- $TMV #AI--Weave Bio, the leader in AI-native regulatory automation for drug development, today announced new global submission capabilities that give drug developmen
Weave Joins athenahealth's Marketplace Program, Giving Healthcare Practices Better Tools for Growth
08:00am, Thursday, 11'th Jun 2026
LEHI, Utah--(BUSINESS WIRE)-- #getweave--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, today announced an agreement with ath
[url="]Weave (NYSE: WEAV)[/url], a leading AI-powered patient communications and payments platform purpose-built for healthcare practices, today announced the
Weave Communications, Inc. (WEAV) Q1 2026 Earnings Call Transcript
08:51pm, Thursday, 30'th Apr 2026
Weave Communications, Inc. (WEAV) Q1 2026 Earnings Call Transcript
Weave Communications, Inc. (WEAV) Q1 Earnings and Revenues Beat Estimates
07:26pm, Thursday, 30'th Apr 2026
Weave Communications, Inc. (WEAV) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.01 per share a year ago.
Weave Announces First Quarter 2026 Financial Results
04:03pm, Thursday, 30'th Apr 2026
LEHI, Utah--(BUSINESS WIRE)--Weave Communications, Inc. (“Weave”) (NYSE: WEAV), a leading vertical SaaS platform that delivers AI-powered patient engagement and payment solutions for small and med
SAN FRANCISCO & RALEIGH, N.C.--(BUSINESS WIRE)-- #Biotech--Weave Bio, the leader in AI-native regulatory automation for drug development, and strategic partner Parexel, a leading global clinical devel
